| 產品名稱 |
Gliocladium sp. |
| 商品貨號 |
B206618 |
| Strain Designations |
F2665 [TC1052] |
| Application |
produces TMC-52 complex |
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
frozen |
| Type Strain |
no |
| Preceptrol® |
no |
| Medium |
ATCC® Medium 323: Malt agar medium
|
| Growth Conditions |
Temperature: 24.0°C |
| Name of Depositor |
T Okuda |
| Special Collection |
NCRR Contract |
| Chain of Custody |
ATCC <<--T Okuda<<--N. Kishi TC1052 |
| Isolation |
rotten leaf of cultivated orchid, Dendrobium phalaenopsis, Warabi-shi, Saitama, Japan |
| References |
Isshiki K, et al. TMC-52A to D, novel cysteine proteinase inhibitors, produced by Gliocladium sp.. J. Antibiot. 51: 629-634, 1998. PubMed: 9727388
|
